
Global Helicobacter Pylori Non-Invasive Testing Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Helicobacter Pylori Non-Invasive Testing market size will reach US$ million by 2031.
United States market for Helicobacter Pylori Non-Invasive Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Helicobacter Pylori Non-Invasive Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Helicobacter Pylori Non-Invasive Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Helicobacter Pylori Non-Invasive Testing players cover Sekisui Diagnostics, Roche, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Helicobacter Pylori Non-Invasive Testing Industry Forecast” looks at past sales and reviews total world Helicobacter Pylori Non-Invasive Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Helicobacter Pylori Non-Invasive Testing sales for 2025 through 2031. With Helicobacter Pylori Non-Invasive Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Helicobacter Pylori Non-Invasive Testing industry.
This Insight Report provides a comprehensive analysis of the global Helicobacter Pylori Non-Invasive Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Helicobacter Pylori Non-Invasive Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Helicobacter Pylori Non-Invasive Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Helicobacter Pylori Non-Invasive Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Helicobacter Pylori Non-Invasive Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Helicobacter Pylori Non-Invasive Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Serology Test
Stool Antigen Test
Urea Breath Test
Segmentation by Application:
Hospitals
Physical Examination Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sekisui Diagnostics
Roche
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Cardinal Health
Danaher
Agilent Technologies
Coris BioConcept
Please note: The report will take approximately 2 business days to prepare and deliver.
United States market for Helicobacter Pylori Non-Invasive Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Helicobacter Pylori Non-Invasive Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Helicobacter Pylori Non-Invasive Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Helicobacter Pylori Non-Invasive Testing players cover Sekisui Diagnostics, Roche, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Helicobacter Pylori Non-Invasive Testing Industry Forecast” looks at past sales and reviews total world Helicobacter Pylori Non-Invasive Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Helicobacter Pylori Non-Invasive Testing sales for 2025 through 2031. With Helicobacter Pylori Non-Invasive Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Helicobacter Pylori Non-Invasive Testing industry.
This Insight Report provides a comprehensive analysis of the global Helicobacter Pylori Non-Invasive Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Helicobacter Pylori Non-Invasive Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Helicobacter Pylori Non-Invasive Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Helicobacter Pylori Non-Invasive Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Helicobacter Pylori Non-Invasive Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Helicobacter Pylori Non-Invasive Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Serology Test
Stool Antigen Test
Urea Breath Test
Segmentation by Application:
Hospitals
Physical Examination Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sekisui Diagnostics
Roche
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Cardinal Health
Danaher
Agilent Technologies
Coris BioConcept
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
115 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Helicobacter Pylori Non-Invasive Testing Market Size by Player
- 4 Helicobacter Pylori Non-Invasive Testing by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Helicobacter Pylori Non-Invasive Testing Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.